๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
Tenax Therapeutics, Inc. (TENX)
NASDAQ: TENX ยท Real-Time Price ยท USD
1.250
-0.140 (-10.07%)
Nov 20, 2026, 4:00 PM EST - Market closed

Tenax Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Profit
------
Operating Income
-69.53-56.39-19.49-8.23-11.05-31.53
Net Income
-65.76-52.6-17.6-7.71-11.05-32.47
Earnings Per Share
-1.38-1.34-1.15-31.04-600.72-2525.03
EPS Growth
------

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
113.7397.5794.859.792.125.58
Total Debt
---0.50.810.29
Net Cash (Debt)
113.7397.5794.859.291.325.29
Net Cash Growth
14.45%2.86%920.89%606.12%-75.14%-17.40%
Net Cash Per Share
2.392.496.2137.4071.55411.57

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-49.35-35.8-14.81-5.9-11.39-10.86
Capital Expenditures
-----0-0.01
Free Cash Flow
-49.35-35.8-14.81-5.9-11.39-10.86
Free Cash Flow Growth
------

Valuation

Selected indicators aren't available for this stock.